Posted from: Thursday, January 16, 2014 - 12:41 PM - Present

DRUG RECALL - Liptruzet used to treat LDL (bad) cholesterol

January 14, 2014, Merck & Co. issued a voluntary recall of Liptruzet because there were defects in the medication’s foil packaging.  It is possible that the packaging defect could allow moisture and air in which may decrease the medication’s effectiveness.

Liptruzet is a combination drug that is used to treat LDL (bad) cholesterol in two ways;  it reduces naturally occurring cholesterol levels and it works to block the body’s absorption of cholesterol. 

The recall covers all 4 lots of this medication that have been produced since Liptruzet was first introduced in May 2013, it also includes all dosage strengths. 

Patients taking Liptruzet may continue taking the drug.  If you have any questions about this recall please contact your local retail pharmacist or speak to your doctor.

No adverse health reactions have been associated with this recall.

Adverse events that may be related to the use of this product may also be reported to the United States Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting Program either online, by regular mail, or by fax:

Online: www.fda.gov/medwatch/report.htm

Regular Mail: use postage-paid FDA form 3500 available at: www.fda.gov/MedWatch/getforms.htm.  Mail the form to: MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787

Fax: 1-800-FDA-0178

Last Updated Sunday, June 18, 2017 - 07:24 PM.